Piloting home infusions of Tysabri (natalizumab): a randomised crossover trial
We developed a new model of care for home infusions of natalizumab for people with multiple sclerosis. The new model of care was then tested in a pilot study comparing home infusions of natalizumab with usual care (attendance in an ambulatory care day units) using an AB/BA randomised crossover trial...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Ubiquity Press
2019-08-01
|
Series: | International Journal of Integrated Care |
Subjects: | |
Online Access: | https://www.ijic.org/articles/5372 |